Twitter Summary: @AmDiabetesAssn updates standards for medical care of #diabetes – suggests all #PWD use statin therapy, and a new BMI cutoff for Asian Americans The...

diaTribe interviews new ADA CEO Kevin Hagan on his goals for the future of the scientific and advocacy powerhouse and diabetes at large.

DiabetesMine’s Innovation Summit shares updates on device connectivity, stigma research, the Bionic Pancreas, and more!

Combining pump, CGM, meter, exercise, and carb data in a cool new interface…

Twitter Summary: Updated meter has color-coded range indicator + provides feedback on glucose values, available at $19.99 nationwide LifeScan recently announced the US...

What this dramatic movement in obesity therapy means for patients in Europe.

Twitter summary: FDA approves Novo Nordisk’s chronic weight management drug Saxenda, another option to help treat #obesity On December 23, the FDA approved Novo Nordisk’...

(S)he said what?!

Integrated care, artificial pancreas, and personalized treatments – the goals of this innovative partnership.

Plus, tips for traveling safely with diabetes.

Praluent now approved for two specific patient populations. How this drug has the future potential to make a big impact on people with diabetes.

Enrolling now – how this implanted CGM compares to current CGM offerings.

$199 keychain device available for patients with Apple iPhone and iPod Touch.

Why it may suggest shifting attitudes towards body image – and not in a good way.

Kelly’s take on connecting through technology at AADE15.

Hello there from San Francisco! I wanted to weigh in, so to speak, on Adam Brown’s valuable column this month . His in-depth inquiry shows what a “low-carb” and “non-low...

Medicare Advantage pilot study shows average of 8.7% weight loss after six months.

The story of one boy’s struggle with stigma.

Comment by March 26 to ensure that diabetes devices easily communicate with one another, other devices, and software.

Two new large studies investigate Finerenone in type 2 diabetes.